Owen Adams Catherine 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed Jun 23, 2026
Research Summary
AI-generated summary of this filing
AGIO Director Owen Adams Catherine Exercises Options, Receives RSUs
What Happened
- Owen Adams Catherine (Director) reported multiple equity-related transactions on June 18, 2026. She exercised or converted derivative rights for 2,816 shares (reported at $0.00) and had a corresponding derivative disposition reported for the same 2,816 shares. She was also granted/awarded a total of 17,877 restricted stock units (2,927 and 14,950), all reported at $0.00. No cash value is shown in the filing for these transactions.
Key Details
- Transaction date: June 18, 2026; reported file date: June 23, 2026 (filed 5 calendar days later; appears to be 1 business day late under the 2-business-day Form 4 rule).
- Prices: all transactions reported at $0.00 per share (common for option exercises with no cash exchanged and for RSU awards).
- Shares involved: exercised/conversion of 2,816 shares; grants/awards of 2,927 and 14,950 RSUs (total 17,877).
- Shares owned after transaction: not specified in the excerpt provided.
- Footnotes of note:
- F1: Each restricted stock unit (RSU) converts to one share upon vesting.
- F2: The 2,927 RSUs were originally granted June 18, 2025 and vest in full on June 18, 2026; vested shares will be delivered within three business days after vesting.
- F3: The 14,950 RSUs were granted June 18, 2026 and vest in full on June 18, 2027; delivery within three business days after vesting.
- F4: Options referenced were granted June 18, 2026 and vest 100% on June 18, 2027.
- No open-market sale or purchase price is reported; these appear to be routine equity compensation events rather than market trades.
Context
- For retail investors: these entries reflect compensation and option/RSU activity — not a straightforward buy or sell in the open market. The exercised/converted 2,816-share line and the matching derivative disposition are reporting conventions for option exercises/conversions and do not necessarily indicate an immediate market sale of shares.
- The RSU grants have future vesting schedules; only the 2,927 RSUs (granted in 2025) vest in full on June 18, 2026 and are to be delivered within three business days. The larger awards/options vest on June 18, 2027.
- Because filing timeliness matters, note the Form 4 was filed after the usual 2-business-day window, which is worth watching but common for administrative delays.
Insider Transaction Report
Form 4
Owen Adams Catherine
Director
Transactions
- Exercise/Conversion
Common stock
2026-06-18+2,816→ 10,865 total - Exercise/Conversion
Restricted stock units
[F1][F2]2026-06-18−2,816→ 0 total→ Common stock (2,816 underlying) - Award
Restricted stock units
[F1][F3]2026-06-18+2,927→ 2,927 total→ Common stock (2,927 underlying) - Award
Stock options (right to buy)
[F4]2026-06-18+14,950→ 14,950 totalExercise: $34.16Exp: 2036-06-18→ Common stock (14,950 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
- [F3]The restricted stock units were granted on June 18, 2026. The shares underlying the stock units will vest in full on June 18, 2027. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
- [F4]These options were granted on June 18, 2026. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2027.
Signature
/s/ William Cook, as attorney-in-fact for Catherine Owen|2026-06-23